Kite Pharma, Inc. drugs

2 results

  • tecartus

    (Brexucabtagene Autoleucel)
    Kite Pharma, Inc.
    Tecartus is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory mantle cell lymphoma (MCL) or relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
    Medication Details
    Drug Interactions

  • yescarta

    (Axicabtagene Ciloleucel)
    Kite Pharma, Inc.
    Yescarta is a CAR-T cell therapy for adults with large B-cell lymphoma refractory to or relapsing after first-line chemoimmunotherapy, or after two or more prior therapies. Also indicated for relapsed or refractory follicular lymphoma after two or more lines of systemic therapy (accelerated approval).
    Medication Details
    Drug Interactions